Itopride Sustained Release Rabeprazole Capsules

This itopride sustained release rabeprazole capsules are indicated for the long-term prophylaxis of gastric ulcers associated with NSAID and other disease states, such as Zollinger-Ellison syndrome. This itopride sustained release rabeprazole capsule is an antacid a proton pump inhibitor for the treatment of duodenal ulcers. It reduces acid secretion in the stomach, which fights stomach ulcers. Rabeprazole itopride sustained release is a proton pump inhibitor (PPI) indicated for the treatment of duodenal ulcers. Rabeprazole reduces gastric acid secretion and inhibits the gastric acid pump, as well as performs some of its anti-secretory effects in the small intestine.